

Pilot Perfusion Bioreactor
中试灌流生物反应器
- SKU PIB-0004
- Pilot Bioreactors
- CE (to be confirmed)
- ISO 13485 manufacturing (to be confirmed)
- 21 CFR Part 11 software documentation (to be confirmed)
Price on request — FOB / CIF quoted per order
Prices depend on configuration, quantity and destination port.
Key specifications
| Working volume | 50–500 L |
|---|---|
| Perfusion rate | 0.5–5 vessel volumes per day |
| Cell retention | ATF, TFF, spin filter or settler |
| Viable cell density | Up to 100 × 10^6 cells/mL |
| Material | Stainless steel or single-use |
| Run duration | Weeks to months |
By Lab Manufacturers China Technical TeamLast reviewed Standards: EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11
What is the Pilot Perfusion Bioreactor?
A pilot perfusion bioreactor continuously feeds medium and removes spent medium while retaining cells, supporting high densities and continuous harvest. It is used for intensified production, labile products and continuous biomanufacturing campaigns.
What is the Pilot Perfusion Bioreactor?
A pilot perfusion bioreactor continuously feeds medium and removes spent medium while retaining cells, supporting high densities and continuous harvest. It is used for intensified production, labile products and continuous biomanufacturing campaigns.
Overview
A pilot perfusion bioreactor keeps cells in the vessel while fresh medium flows in and product-containing spent medium flows out. Retention is achieved with an alternating tangential flow filter, a tangential flow membrane, a spin filter or a settler, and the perfusion rate is set in vessel volumes per day according to the cell-specific demand. Removing inhibitory metabolites and replenishing nutrients allows very high viable cell densities and continuous product harvest, which suits labile molecules and reduces vessel size for a given output. Designs may be stirred stainless or single-use, and reliable pumps, filter pressure monitoring and a controlled cell bleed are essential because fouling and washout are the main risks over runs of weeks. Clean-in-place or disposable fluid paths are chosen according to the facility.
How does it work?
A pilot bioreactor applies the same biological principles as a smaller vessel but at a scale where mixing, oxygen transfer and heat removal behave differently. Larger impellers and higher gas flow increase oxygen transfer, described by the volumetric mass-transfer coefficient, while a jacket or coil removes the greater metabolic heat load. Sensors for temperature, pH, dissolved oxygen, pressure and often foam or level sit in hygienic fittings, and cascade control adjusts agitation, gas composition and back pressure to hold dissolved oxygen. Because mixing time, tip speed and mass-transfer coefficient cannot all be matched to bench scale, engineers choose the most critical criterion and verify performance during the run. Pilot vessels may be reusable stainless steel or single-use, and they include defined sampling, feed and harvest points.
What are the key features?
- Continuous medium exchange with cell retention
- ATF, TFF, spin filter or settler devices
- Perfusion rate control in vessel volumes per day
- Continuous product harvest
- Filter pressure monitoring for fouling detection
What are the technical specifications?
A typical pilot perfusion bioreactor configuration offers working volume of 50–500 L, perfusion rate of 0.5–5 vessel volumes per day, cell retention of ATF, TFF, spin filter or settler, viable cell density of Up to 100 × 10^6 cells/mL, material of Stainless steel or single-use and run duration of Weeks to months. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.
Which applications is it used for?
The Pilot Perfusion Bioreactor is used in high-density production culture, unstable product manufacturing, continuous biomanufacturing and intensified process development. Across the wider Pilot Bioreactors class, laboratories also deploy it for scale-up verification, clinical and trial batch production and monoclonal antibody and protein production.
Which standards and certifications apply?
Relevant standards and methods include EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11, 21 CFR Part 211, GB/T 150, ISO 13485, USP <87>, USP <88>, ICH Q11 and IEC 61010-1. Certification candidates for this model are CE, ISO 13485 manufacturing and 21 CFR Part 11 software documentation; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.
Qualify the vessel and its utilities with documented pressure, temperature, cleaning and sterilization tests. Calibrate pH and dissolved oxygen probes before each run and verify sensor placement so readings reflect bulk conditions. Establish the scale-up criterion and document why it was chosen, then record the supporting data. Monitor foam, heat removal and dissolved oxygen closely, since these are the usual scale-dependent problems. Keep batch records that capture setpoints, deviations and offline measurements such as cell count and metabolite levels. For reusable vessels, control cleaning cycles and gaskets; for single-use, manage bag lots, integrity and extractables data. Confirm electrical safety to IEC 61010-1.
How do I select the right Pilot Perfusion Bioreactor?
Choose pilot perfusion when high density, continuous harvest or product instability justifies the complexity. In an RFQ specify volume, retention technology, perfusion rate range, filter monitoring, run duration and the control, sampling and cleaning features required.
How does it compare with other Pilot Bioreactors variants?
Size the vessel to reproduce the most important bench parameter and to produce enough material for the next step, whether that is a clinical batch, a trial quantity or data for production design. Decide between stainless steel, which suits repeated campaigns and higher pressure, and single-use, which shortens changeover and reduces cleaning validation. Match the geometry, impeller type and gas handling to the scale-up criterion you intend to hold constant. List control loops and ranges, the number of feed, sampling and harvest ports, and whether redox, off-gas analysis or back pressure control are needed. Evaluate clean-in-place and sterilize-in-place for reusable designs, single-use bag performance for disposable designs, and the records and qualification package available for regulated work.
Full specifications
| Working volume | 50–500 L |
|---|---|
| Perfusion rate | 0.5–5 vessel volumes per day |
| Cell retention | ATF, TFF, spin filter or settler |
| Viable cell density | Up to 100 × 10^6 cells/mL |
| Material | Stainless steel or single-use |
| Run duration | Weeks to months |
| Harvest mode | Continuous with pool collection |
| Cleaning | Clean in place or disposable path |
Indicative values for this product class. Final specifications are confirmed on the quotation and in the calibration documents supplied with the instrument.
Applications
- High-density production culture
- Unstable product manufacturing
- Continuous biomanufacturing
- Intensified process development
Key features
- Continuous medium exchange with cell retention
- ATF, TFF, spin filter or settler devices
- Perfusion rate control in vessel volumes per day
- Continuous product harvest
- Filter pressure monitoring for fouling detection
Frequently asked questions about Pilot Perfusion Bioreactor
Perfusion supports high cell densities and continuous harvest, raising volumetric productivity and shortening residence time for unstable molecules. It also lets a smaller vessel achieve a given output, which can reduce facility footprint and capital cost.
Filter fouling and cell washout are the primary risks, since a blocked retention device or excessive bleed can end a long run. Reliable pumps, pressure monitoring, a controlled bleed and disciplined aseptic technique are essential for stable operation.
No. It is most valuable for labile products, high-density processes and continuous manufacturing, while traditional fed-batch remains simpler and well validated for many antibodies. The choice depends on titre, stability, facility design and cost.
It verifies that a process developed at bench scale behaves as expected at larger volume and it produces enough material for clinical trials, product evaluation or production design. It also reveals scale-dependent effects such as oxygen limitation or poor heat removal.
Constant volumetric mass-transfer coefficient, tip speed, power per volume and mixing time cannot all be held simultaneously. The team selects the criterion most related to product quality or yield, applies it at pilot scale and verifies the result before transferring to production.
Stainless steel suits repeated campaigns, higher pressures and steam sterilization, while single-use suits multi-product or clinical work where cleaning validation between products would be costly. Extractables data, volume and pressure limits and supply continuity guide the single-use choice.
Related models





